Human Factor H Interacts Selectively with Neisseria gonorrhoeae and Results in Species-Specific Complement Evasion
- 1 March 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 180 (5) , 3426-3435
Abstract
Complement forms a key arm of innate immune defenses against gonococcal infection. Sialylation of gonococcal lipo-oligosaccharide, or expression of porin 1A (Por1A) protein, enables Neisseria gonorrhoeae to bind the alternative pathway complement inhibitor, factor H (fH), and evade killing by human complement. Using recombinant fH fragment-murine Fc fusion proteins, we localized two N. gonorrhoeae Por1A-binding regions in fH: one in complement control protein domain 6, the other in complement control proteins 18–20. The latter is similar to that reported previously for sialylated Por1B gonococci. Upon incubation with human serum, Por1A and sialylated Por1B strains bound full-length human fH (HufH) and fH-related protein 1. In addition, Por1A strains bound fH-like protein 1 weakly. Only HufH, but not fH from other primates, bound directly to gonococci. Consistent with direct HufH binding, unsialylated Por1A gonococci resisted killing only by human complement, but not complement from other primates, rodents or lagomorphs; adding HufH to these heterologous sera restored serum resistance. Lipo-oligosaccharide sialylation of N. gonorrhoeae resulted in classical pathway regulation as evidenced by decreased C4 binding in human, chimpanzee, and rhesus serum but was accompanied by serum resistance only in human and chimpanzee serum. Direct-binding specificity of HufH only to gonococci that prevents serum killing is restricted to humans and may in part explain species-specific restriction of natural gonococcal infection. Our findings may help to improve animal models for gonorrhea while also having implications in the choice of complement sources to evaluate neisserial vaccine candidates.Keywords
This publication has 61 references indexed in Scilit:
- West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor HProceedings of the National Academy of Sciences, 2006
- Relapsing Fever SpirochetesBorrelia recurrentisandB. duttoniiAcquire Complement Regulators C4b-Binding Protein and Factor HInfection and Immunity, 2006
- LfhA, a Novel Factor H-Binding Protein of Leptospira interrogansInfection and Immunity, 2006
- Complement Processing and Immunoglobulin Binding toNeisseria gonorrhoeaeDetermined In Vitro Simulates In Vivo EffectsThe Journal of Infectious Diseases, 1999
- Analysis of the recognition mechanism of the alternative pathway of complement by monoclonal anti‐factor H antibodies: evidence for multiple interactions between H and surface bound C3bFEBS Letters, 1996
- Cytidine 5'-Monophospho-N-acetylneuraminic Acid or a Related Compound is the Low Mr Factor from Human Red Blood Cells Which Induces Gonococcal Resistance to Killing by Human SerumMicrobiology, 1988
- Amino acid sequence of rabbit factor H of complement. Purification of peptides produced by cyanogen bromide cleavage.Chemical and Pharmaceutical Bulletin, 1988
- Correlation of Auxotype and Protein I Type with Expression of Disease Due to Neisseria gonorrhoeaeThe Journal of Infectious Diseases, 1985
- Immunological Basis of Serum Resistance of Neisseria gonorrhoeaeMicrobiology, 1982
- Gonococci in Urethral Exudates possess a Virulence Factor lost on SubcultureNature, 1970